| D009369 |
Neoplasms |
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. |
Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant |
|
| D005971 |
Glutamates |
Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure. |
Glutamic Acid Derivatives,Glutamic Acids,Glutaminic Acids |
|
| D006147 |
Guanine |
|
|
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000068437 |
Pemetrexed |
A guanine-derived ANTINEOPLASTIC AGENT that functions as a NUCLEIC ACID SYNTHESIS INHIBITOR through its binding to, and inhibition of, THYMIDYLATE SYNTHASE. |
Alimta,LY 231,514,LY 231514,LY-231,514,LY-231514,LY231514,MTA,N-(4-(2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid,Pemetrexed Disodium,231,514, LY,231514, LY,Disodium, Pemetrexed |
|
| D000964 |
Antimetabolites, Antineoplastic |
Antimetabolites that are useful in cancer chemotherapy. |
Antineoplastic Antimetabolites |
|